LEGN — LEGEND BIOTECH CORPORATION

Ownership history in JOHNSON & JOHNSON  ·  18 quarters on record

This page tracks every 13F SEC filing in which JOHNSON & JOHNSON reported a position in LEGEND BIOTECH CORPORATION (LEGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
25.55% (2023 Q1)
Avg. % of fund
11.59%
First filed
2021 Q3
Last filed
2025 Q4
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 814,586 — 0% 3.19% $17.7M $21.74
2025 Q3 UNCHANGED 814,586 — 0% 5.27% $26.6M $32.61
2025 Q2 UNCHANGED 814,586 — 0% 8.44% $28.2M $35.49
2025 Q1 UNCHANGED 814,586 — 0% 8.08% $27.6M $33.93
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LEGN price (monthly, adj. close)

Other funds also holding LEGN

As of 2025 Q4 — sorted by position size

IvyRock Asset Management (HK) Ltd 3Y 9.22% MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 3Y 7Y 6.31% HHLR ADVISORS, LTD. 3Y 7Y 4.19% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.94% Eagle Health Investments LP 3Y 1.95% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.65% ABS Direct Equity Fund LLC 1.22% BRAIDWELL LP 3Y 0.9% Triata Capital Ltd 0.67% WESTFIELD CAPITAL MANAGEMENT CO LP 3Y 7Y 0.56%
← Back to JOHNSON & JOHNSON Holdings